This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CVS Health Corp (CVS)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 4.64B 4.59B 3.88B 3.46B
Operating Gains/Losses 521.00M 0.00 348.00M -53.00M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -737.00M -2.21B -387.00M -748.00M
(Increase) Decrease in Inventories -770.00M 12.00M -858.00M 607.00M
(Increase) Decrease In Other Current Assets -383.00M 105.00M 3.00M -420.00M
(Decrease) Increase In Payables 1.74B 1.02B 1.15B 1.13B
(Decrease) Increase In Other Current Liabilities 1.06B 471.00M 753.00M 85.00M
(Increase) Decrease In Other Working Capital 22.00M -136.00M 11.00M -47.00M
Other Non-Cash Items 165.00M 141.00M 132.00M 135.00M
Net Cash From Continuing Operations 8.14B 5.78B 6.67B 5.86B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 8.14B 5.78B 6.67B 5.86B
Sale of Property, Plant & Equipment 11.00M 54.00M 23.00M 4.00M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 136.00M 0.00 0.00
Purchases of Property, Plant & Equipment -2.14B -1.98B -2.03B -1.87B
Acquisitions -2.44B -415.00M -371.00M -1.19B
Purchases of Short-Term Investments 0.00 -226.00M 0.00 -3.00M
Other Cash from Investing Activities 676.00M 600.00M 529.00M 592.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -4.04B -1.84B -1.85B -2.41B
Issuance of Debt 1.48B 3.96B 1.24B 1.46B
Cash Used for Financing Activities
Issuance of Capital Stock 421.00M 500.00M 836.00M 431.00M
Repayment of Long-Term Debt -3.10B 0.00 -1.72B -2.12B
Repurchase of Capital Stock -4.00B -3.98B -4.33B -3.00B
Payment of Cash Dividends -1.29B -1.10B -829.00M -674.00M
Other Financing Charges, Net 791.00M -628.00M -58.00M 443.00M
Net Cash From Financing Activities -5.69B -1.24B -4.86B -3.46B
Effect of Exchange Rate Changes -6.00M 3.00M 0.00 0.00
Net Change in Cash & Cash Equivalents -1.61B 2.71B -38.00M -14.00M
CVS News

Analysts Ratings for CVS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 12 13 14
Moderate Buy 3 3 3 3
Hold 2 2 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

CVS Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs